This is on the eve of their interim P2 data release mid April. I wonder if cu6 has at least time til just prior to the release of their dose expansion cohort. This isn't accounting for bombesin either m
hopefully, the SP will rise and there is more competition between BP.
eli lily, Novartis, AZ and BMS have all made plays... hopefully there is more than 1 BP keen on cu6 if it ends up much better than pluvicto.
This is on the eve of their interim P2 data release mid April. I...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.01 |
Change
0.210(7.50%) |
Mkt cap ! $935.4M | |||
| Open | High | Low | Value | Volume |
| $2.77 | $3.04 | $2.76 | $6.224M | 2.101M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 706 | $2.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.02 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$3.00 |
Change
0.210 ( 7.29 %) |
||||
| Open | High | Low | Volume | ||
| $2.79 | $3.04 | $2.79 | 204619 | ||
| Last updated 15.59pm 01/05/2024 ? | |||||
| CU6 (ASX) Chart |